No abstract

Graphene nanosheets are highly recognized for their utility toward the development of biomedical device applications. The present study investigated the antibacterial efficiency of graphene nanosheets against four types of pathogenic bacteria. Graphene nanosheets are synthesized by a hydrothermal approach (under alkaline conditions using hydrazine hydrate). UV–vis and X-ray diffraction show a maximum absorbance at 267 nm and appearance of new broad diffraction peak at 26°, which ensures the reduction of graphene oxide into graphene nanosheets. Stretching and bending vibrations of C–C bonds, chemical states, disorder, and defects associated with the graphene nanosheets are evaluated in comparison with graphene oxide. The minimum inhibitory concentration (MIC) of graphene nanosheets against pathogenic bacteria was evaluated by a microdilution method. MICs such as 1 μg/mL (against Escherichia coli and Salmonella typhimurium), 8 μg/mL (against Enterococcus faecalis), and 4 μg/mL (against Bacillus subtilis) suggest that graphene nanosheets have predominant antibacterial activity compared to the standard antibiotic, kanamycin. Measurement of free radical modulation activity of graphene nanosheets suggested the involvement of reactive oxygen species in antibacterial properties.

Rapid innovations in nanomedicine have increased the likelihood that engineered nanomaterials will eventually come in contact with humans and the environment. The advent of nanotechnology has created strong interest in many fields such as biomedical sciences and engineering field. Central to any significant advances in nanomaterial based applications will be the development of functionalized nanoparticles, which are believed to hold promise for use in fields such as pharmaceutical and biomedical sciences. Early clinical results have suggested that functionalization of nanoparticles with specific recognition chemical moieties indeed yields multifunctional nanoparticles with enhanced efficacy, while simultaneously reducing side effects, due to properties such as targeted localization in tumors and active cellular uptake. A prerequisite for advancing this area of research is the development of chemical methods to conjugate chemical moieties onto nanoparticles in a reliable manner. In recent years a variety of chemical methods have been developed to synthesize functionalized nanoparticles specifically for drug delivery, cancer therapy, diagnostics, tissue engineering and molecular biology, and the structure-function relationship of these functionalized nanoparticles has been extensively examined. With the growing understanding of methods to functionalize nanoparticles and the continued efforts of creative scientists to advance this technology, it is likely that functionalized nanoparticles will become an important tool in the above mentioned areas. Therefore, the aim of this review is to provide basic information on nanoparticles, describe previously developed methods to functionalize nanoparticles and discuss their potential applications in biomedical sciences. The information provided in this review is important in regards to the safe and widespread use of functionalized nanoparticles particularly in the biomedicine field.

No abstract

Since the last two decades, protein conjugated fluorescent gold nanoclusters (NCs) owe much attention in the field of medical and nanobiotechnology due to their excellent photo stability characteristics. In this paper, we reported stable, nontoxic and red fluorescent emission BSA-Au NCs for selective detection of L-dopamine (DA) in cerebrospinal fluid (CSF). The evolution was probed by various instrumental techniques such as UV-vis spectroscopy, High resolution transmission electron microscopy (HTEM), X-ray photoelectron spectroscopy (XPS), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), photoluminescence spectroscopy (PL). The synthesised BSA-Au NCs were showing 4–6 nm with high fluorescent ~8% Quantum yield (QY). The fluorescence intensity of BSA-Au NCs was quenched upon the addition of various concentrations of DA via an electron transfer mechanism. The decrease in BSA-Au NCs fluorescence intensity made it possible to determine DA in PBS buffer and the spiked DA in CSF in the linear range from 0 to 10 nM with the limit of detection (LOD) 0.622 and 0.830 nM respectively. Best of our knowledge, as-prepared BSA-Au NCs will gain possible strategy and good platform for biosensor, drug discovery, and rapid disease diagnosis such as Parkinson’s and Alzheimer diseases.